South Western Sydney Clinical School

Ho V; Chung L; Singh A; Lea V; Abubakar A; Lim SH; Ng W; Lee M; de Souza P; Shin JS; Lee CS, 2018, 'Overexpression of the MRE11-RAD50-NBS1 (MRN) complex in rectal cancer correlates with poor response to neoadjuvant radiotherapy and prognosis', BMC Cancer, vol. 18, http://dx.doi.org/10.1186/s12885-018-4776-9

Sun L; Fahey P; Zhu X; Ng W; Chen ZP; Qiu Y; Lai H; Lin J; Lin L, 2018, 'A Cohort Study to Examine the Use of Chinese Herbal Medicine in Combination With Conventional Therapies for Patients With Hepatocellular Carcinoma in China', Integrative Cancer Therapies, vol. 17, pp. 902 - 911, http://dx.doi.org/10.1177/1534735418775819

Girgis A; Durcinoska I; Gerges M; Kaadan N; Arnold A; Descallar J; Delaney GP; Avery S; Carolan M; Della-Fiorentina S; Masters K; Miller A; Ng W; Sandell T; Tran TT; Levesque JV, 2018, 'Study protocol for a controlled trial of an eHealth system utilising patient reported outcome measures for personalised treatment and care: PROMPT-Care 2.0', BMC Cancer, vol. 18, http://dx.doi.org/10.1186/s12885-018-4729-3

Girgis A; Durcinoska I; Delaney GP; Koh ES; Ng W; Arnold A, 2018, 'Development of health pathways to standardize cancer care pathways informed by patient-reported outcomes and clinical practice guidelines', JCO Clinical Cancer Informatics, vol. 2018, pp. 1 - 13, http://dx.doi.org/10.1200/CCI.18.00024

Ho V; Chung L; Singh A; Lea V; Revoltar M; Lim SH; Tut TG; Ng W; Lee M; de Souza P; Shin JS; Lee CS, 2017, 'Early postoperative low expression of RAD50 in rectal cancer patients associates with disease-free survival', Cancers, vol. 9, http://dx.doi.org/10.3390/cancers9120163

Huang YTT; Park J; Chong S; Hugh TJ; Ng WL; Lin M, 2017, 'The prognostic value of fluorodeoxyglucose positron emission tomography metabolic tumor volume in solitary colorectal liver metastasis', Asia-Pacific Journal of Clinical Oncology, vol. 13, pp. e262 - e270, http://dx.doi.org/10.1111/ajco.12568

Mak M; Bell K; Ng W; Lee M, 2017, 'Nutritional status, management and clinical outcomes in patients with esophageal and gastro-oesophageal cancers: A descriptive study', Nutrition and Dietetics, vol. 74, pp. 229 - 235, http://dx.doi.org/10.1111/1747-0080.12306

Manoharan V; Lee S; Chong S; Yap J; Coupe N; Wilson R; Merrett N; Ng W; Lin M, 2017, 'Serial imaging using [18F]Fluorodeoxyglucose positron emission tomography and histopathologic assessment in predicting survival in a population of surgically resectable distal oesophageal and gastric adenocarcinoma following neoadjuvant therapy', Annals of Nuclear Medicine, vol. 31, pp. 315 - 323, http://dx.doi.org/10.1007/s12149-017-1159-2

Brungs D; Aghmesheh M; de Souza P; Ng W; Chua W; Carolan M; Clingan P; Healey E; Rose J; Tubaro T; Ranson M, 2017, 'Sidedness is prognostic in locoregional colon cancer: An analysis of 9509 Australian patients', BMC Cancer, vol. 17, http://dx.doi.org/10.1186/s12885-017-3255-z

Toh JWT; de Souza P; Lim SH; Singh P; Chua W; Ng W; Spring KJ, 2016, 'The Potential Value of Immunotherapy in Colorectal Cancers: Review of the Evidence for Programmed Death-1 Inhibitor Therapy', Clinical Colorectal Cancer, vol. 15, pp. 285 - 291, http://dx.doi.org/10.1016/j.clcc.2016.07.007

Ho V; Chung L; Revoltar M; Lim SH; Tut TG; Abubakar A; Henderson CJ; Chua W; Ng W; Lee M; De Souza P; Morgan M; Lee CS; Shin JS, 2016, 'MRE11 and ATM expression levels predict rectal cancer survival and their association with radiotherapy response', PLoS ONE, vol. 11, http://dx.doi.org/10.1371/journal.pone.0167675

Girgis A; Delaney GP; Arnold A; Miller AA; Levesque JV; Kaadan N; Carolan MG; Cook N; Masters K; Tran TT; Sandell T; Durcinoska I; Gerges M; Avery S; Ng W; Della-Fiorentina S; Dhillon HM; Maher A, 2016, 'Development and Feasibility Testing of PROMPT-Care, an eHealth System for Collection and Use of Patient-Reported Outcome Measures for Personalized Treatment and Care: A Study Protocol', JMIR RESEARCH PROTOCOLS, vol. 5, http://dx.doi.org/10.2196/resprot.6459

Gormly KL; Coscia C; Wells T; Tebbutt N; Harvey JA; Wilson K; Schmoll HJ; Price T; Price T; Hruby G; Jeffery M; Karapetis C; Ng W; Singhal N; Burge M; Lynch R; Briscoe K; Begbie S; Gill S; Sebesan S; Goldstein D; Ng S; Asghari R; Blum R; Walpole E; Byard I, 2016, 'MRI rectal cancer in Australia and New Zealand: An audit from the PETACC-6 trial', Journal of Medical Imaging and Radiation Oncology, vol. 60, pp. 607 - 615, http://dx.doi.org/10.1111/1754-9485.12493

Wilkinson KJ; Chua W; Ng W; Roohullah A, 2015, 'Management of asymptomatic primary tumours in stage IV colorectal cancer: Review of outcomes', World Journal of Gastrointestinal Oncology, vol. 7, pp. 513 - 523, http://dx.doi.org/10.4251/wjgo.v7.i12.513

Tut TG; Lim SHS; Dissanayake IU; Descallar J; Chua W; Ng W; De Souza P; Shin JS; Lee CS, 2015, 'Upregulated polo-like kinase 1 expression correlates with inferior survival outcomes in rectal cancer', PLoS ONE, vol. 10, http://dx.doi.org/10.1371/journal.pone.0129313

Sze M; Butow P; Bell M; Vaccaro L; Dong S; Eisenbruch M; Jefford M; Girgis A; King M; McGrane J; Ng W; Asghari R; Parente P; Liauw W; Goldstein D; Psycho-oncology Co-operative Research Group Culturally and Linguistically Diverse (CALD) TEAM , 2015, 'Migrant health in cancer: outcome disparities and the determinant role of migrant-specific variables', Oncologist, vol. 20, pp. 523 - 531, http://dx.doi.org/10.1634/theoncologist.2014-0274

Jacob SA; Ng WL; Do V, 2015, 'Estimation of an Optimal Chemotherapy Utilisation Rate for Cancer: Setting an Evidence-based Benchmark for Quality Cancer Care', Clinical Oncology, vol. 27, pp. 77 - 82, http://dx.doi.org/10.1016/j.clon.2014.10.004

Kao SCH; van Zandwijk N; Clarke S; Vardy J; Lumba S; Tognela A; Ng W, 2015, 'Estimation of an optimal chemotherapy utilization rate for malignant pleural mesothelioma: An evidence-based benchmark for cancer care', Asia-Pacific Journal of Clinical Oncology, vol. 11, pp. 85 - 92, http://dx.doi.org/10.1111/ajco.12306

Ng W; Jacob S; Delaney G; Do V; Barton M, 2015, 'Estimation of an optimal chemotherapy utilisation rate for upper gastrointestinal cancers: Setting an evidence-based benchmark for the best-quality cancer care', Gastroenterology Research and Practice, vol. 2015, http://dx.doi.org/10.1155/2015/753480

Roohullah A; Wong HL; Sjoquist KM; Gibbs P; Field K; Tran B; Shapiro J; McKendrick J; Yip D; Nott L; Gebski V; Ng W; Chua W; Price T; Tebbutt N; Chantrill L, 2015, 'Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumab', World Journal of Gastroenterology, vol. 21, pp. 5352 - 5358, http://dx.doi.org/10.3748/wjg.v21.i17.5352

Lim SH; Chua W; Henderson C; Ng W; Shin JS; Chantrill L; Asghari R; Lee CS; Spring KJ; de Souza P, 2015, 'Predictive and prognostic biomarkers for neoadjuvant chemoradiotherapy in locally advanced rectal cancer', Critical Reviews in Oncology/Hematology, vol. 96, pp. 67 - 80, http://dx.doi.org/10.1016/j.critrevonc.2015.05.003

Lim SHS; Becker TM; Chua W; Ng WL; De Souza P; Spring KJ, 2014, 'Circulating tumour cells and the epithelial mesenchymal transition in colorectal cancer', Journal of Clinical Pathology, vol. 67, pp. 848 - 853, http://dx.doi.org/10.1136/jclinpath-2014-202499

Do V; Ng W; Delaney G; Barton M, 2014, '606PAN ESTIMATION OF THE POPULATION SURVIVAL BENEFIT OF FIRST-LINE CHEMOTHERAPY FOR GASTROINTESTINAL CANCER.', Ann Oncol, vol. 25, pp. iv206 - iv207, http://dx.doi.org/10.1093/annonc/mdu333.107

Lim SH; Becker TM; Chua W; Caixeiro NJ; Ng WL; Kienzle N; Tognela A; Lumba S; Rasko JEJ; De Souza P; Spring KJ, 2014, 'Circulating tumour cells and circulating free nucleic acid as prognostic and predictive biomarkers in colorectal cancer', Cancer Letters, vol. 346, pp. 24 - 33, http://dx.doi.org/10.1016/j.canlet.2013.12.019

Coupe NA; Karikios D; Chong S; Yap J; Ng W; Merrett N; Lin M, 2014, 'Metabolic information on staging FDG-PET-CT as a prognostic tool in the evaluation of 97 patients with gastric cancer', Annals of Nuclear Medicine, vol. 28, pp. 128 - 135, http://dx.doi.org/10.1007/s12149-013-0791-8

Goldstein D; Bell ML; Butow P; Sze M; Vaccaro L; Dong S; Liauw W; Hui R; Tattersall M; Ng W; Asghari R; Steer C; Vardy J; Parente P; Harris M; Karanth NV; King M; Girgis A; Eisenbruch M; Jefford M, 2014, 'Immigrants' perceptions of the quality of their cancer care: An Australian comparative study, identifying potentially modifiable factors', Annals of Oncology, vol. 25, pp. 1643 - 1649, http://dx.doi.org/10.1093/annonc/mdu182

Lim SHS; Chua W; Cheng C; Descallar J; Ng W; Solomon M; Bokey L; Wong K; Lee MT; De Souza P; Shin JS; Lee CS, 2014, 'Effect of neoadjuvant chemoradiation on tumor-infiltrating/associated lymphocytes in locally advanced rectal cancers', Anticancer Research, vol. 34, pp. 6505 - 6513

Fong A; Shafiq J; Saunders C; Thompson A; Tyldesley S; Olivotto IA; Barton MB; Dewar J; Jacob SA; Ng W; Speers CH; Delaney GP, 2012, 'A comparison of surgical and radiotherapy breast cancer therapy utilization in Canada (British Columbia), Scotland (Dundee), and Australia (Western Australia) with models of "optimal" therapy', Breast, vol. 21, pp. 570 - 577, http://dx.doi.org/10.1016/j.breast.2012.02.014

Shafiq J; Saunders C; Thompson A; Tyldesley S; Olivotto IA; Barton MB; Dewar J; Ng W; Speers CH; Delaney GP, 2012, 'A comparison of systemic breast cancer therapy utilization in Canada (British Columbia), Scotland (Dundee), and Australia (Western Australia) with models of “optimal” therapy', Breast, vol. 21, pp. 562 - 569, http://dx.doi.org/10.1016/j.breast.2012.01.006

Luckett T; Goldstein D; Butow PN; Gebski V; Aldridge LJ; McGrane J; Ng W; King MT, 2011, 'Psychological morbidity and quality of life of ethnic minority patients with cancer: A systematic review and meta-analysis', The Lancet Oncology, vol. 12, pp. 1240 - 1248, http://dx.doi.org/10.1016/S1470-2045(11)70212-1

Jacob S; Ng W; Delaney GP; Barton MB, 2011, 'Estimation of an Optimal Chemotherapy Utilisation Rate for Primary Malignant Brain Tumours: an Evidence-based Benchmark for Cancer Care', CLINICAL ONCOLOGY, vol. 23, pp. 48 - 54, http://dx.doi.org/10.1016/j.clon.2010.08.011

Lin M; Wong K; Ng WL; Shon IH; Morgan M, 2011, 'Positron emission tomography and colorectal cancer', Critical Reviews in Oncology/Hematology, vol. 77, pp. 30 - 47, http://dx.doi.org/10.1016/j.critrevonc.2010.04.011

Jacob SA; Ng W; Asghari R; Delaney GP; Barton MB, 2011, 'Chemotherapy in rectal cancer: variation in utilization and development of an evidencebased benchmark rate of optimal chemotherapy utilization', Clinical Colorectal Cancer, vol. 10, pp. 102 - 107, http://dx.doi.org/10.1016/j.clcc.2011.03.005

Jacob SA; Ng W; Delaney GP; Barton MB, 2011, 'Estimation of an optimal chemotherapy utilisation rate for primary malignant brain tumours: an evidence-based benchmark for cancer care', Clinical Oncology, vol. 23, pp. 48 - 54, http://dx.doi.org/10.1016/j.clon.2010.08.011

Luckett T; Goldstein D; Butow PN; Gebski V; Aldridge L; McGrane J; Ng W; King MT, 2011, 'Psychological morbidity and quality of life of ethnic minority patients with cancer: a systematic review and meta-analysis', Lancet Oncology, vol. 12, pp. 1240 - 1248, http://dx.doi.org/10.1016/S1470

Ng WL; Della-Fiorentina SA, 2010, 'The efficacy of oral ondansetron and dexamethasone for the prevention of acute chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy - a retrospective audit', European Journal of Cancer Care, vol. 19, pp. 403 - 407, http://dx.doi.org/10.1111/j.1365-2354.2009.01068.x

Ng W; Jacob SA; Delaney GP; Barton MB, 2010, 'Chemotherapy in Head and Neck Cancers: Summary of Recommendations and a Critical Review of Clinical Practice Guidelines', The European Journal of Clinical and Medical Oncology, vol. 2, pp. 65 - 71

Ng W; Delaney GP; Jacob SA; Barton MB, 2010, 'Estimation of an optimal chemotherapy utilisation rate for breast cancer: Setting an evidence-based benchmark for the best quality cancer care.', European Journal of Cancer, vol. 46, pp. 703 - 712, http://dx.doi.org/10.1016/j.ejca.2009.12.002

Ng W, 2007, 'Breast Cancer Research Protocols', CANCER FORUM, vol. 31, pp. 113 - 113, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000213384600011&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ng WL; Gabriel G; Moylan E, 2006, 'Predictive factors for the underutilization of adjuvant chemotherapy in colon cancer in Southwestern Sydney.', J Clin Oncol, vol. 24, pp. 6070, http://www.ncbi.nlm.nih.gov/pubmed/27954818

Girgis A; Durcinoska I; Arnold A; Descallar J; Kaadan N; Koh E-S; Miller A; Ng W; Carolan M; Della-Fiorentina SA; Avery S; Delaney GP, 'Web-Based Patient-Reported Outcome Measures for Personalized Treatment and Care (PROMPT-Care): Multicenter Pragmatic Nonrandomized Trial (Preprint)', , http://dx.doi.org/10.2196/preprints.19685

Lim SH-S; Shin J-S; Tut TG; Ng WTW; Chug W; Dissanayake IU; Spring K; Ng W; Bokey L; De Souza P; Lee CS, 2014, 'Polo-like kinase 1 as a biomarker in rectal cancers', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Chicago, IL, presented at 50th Annual Meeting of the American-Society-of-Clinical-Oncology, Chicago, IL, 30 May 2014 - 03 June 2014, http://dx.doi.org/10.1200/jco.2014.32.15_suppl.e14542

Roohullah A; Sjoquist KM; Gebski V; Ng W; Chua W; Price TJ; Tebbutt NC; Chantrill LA, 2014, 'The efficacy and safety outcomes of bevacizumab and systemic therapy in metastatic colorectal cancer patients with peritoneal disease in the AGITG MAX clinical trial and in nontrial patients in two cancer centers.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, San Francisco, CA, presented at Gastrointestinal Cancers Symposium, San Francisco, CA, 16 January 2014 - 18 January 2014, http://dx.doi.org/10.1200/jco.2014.32.3_suppl.595

Tognela A; Kao S; Van Zandwijk N; Clarke S; Vardy J; Bray V; Lumba S; Ng W, 2013, 'ESTIMATION OF AN OPTIMAL CHEMOTHERAPY UTILISATION RATE FOR MALIGNANT PLEURAL MESOTHELIOMA: AN EVIDENCE-BASED BENCHMARK FOR PATIENT CARE', in JOURNAL OF THORACIC ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, pp. S642 - S643, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339624903071&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lumba S; Lin M; Xuan W; Tognela A; Lim S; Hugh T; Chua W; Ng W, 2013, 'COLORECTAL CANCER PATIENTS WITH ISOLATED LIVER METASTASES - A RETROSPECTIVE REVIEW AND OUTCOMES POST-METASTASECTOMY STRATIFIED BY KRAS STATUS', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 59 - 59, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000329462300039&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Park C; Lin M; Hugh T; Ng W, 2012, 'THE PROGNOSTIC UTILITY OF METABOLIC INFORMATION PROVIDED BY FDG PET IN THE EVALUATION OF SOLITARY COLORECTAL HEPATIC METASTASES', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS, Barcelona, SPAIN, pp. 21 - 21, presented at 14th World Congress on Gastrointestinal Cancer of the European-Society-for-Medical-Oncology (ESMO), Barcelona, SPAIN, 27 June 2012 - 30 June 2012, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000305826900036&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ng WL; Gabriel G; Moylan E, 2006, 'Predictive factors for the underutilization of adjuvant chemotherapy in colon cancer in Southwestern Sydney.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Atlanta, GA, pp. 318S - 318S, presented at 42nd Annual Meeting of the American-Society-of-Clinical-Oncology, Atlanta, GA, 02 June 2006 - 06 June 2006, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000239009402141&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Duggan KJ; Chandra A; Berthelsen A; Sharmin M; Kaadan N; Deshmukh V; Ng W; Seccombe D; Johnston M; Descallar J, 2018, 'Colon cancer stage and treatment patterns in relation to culturally and linguistically diverse status, in South West Sydney Local Health District', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 14, pp. 93 - 94, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449544200117&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Rachumalla PR; Carson E; Cooper A; Wilkinson K; Asghari R; Adams D; Ng W; Chua W; Roohullah A; De Souza P, 2018, 'Retrospective analysis of clinical characteristics and outcomes for patients enrolled in oncology phase 0 and phase 1 clinical trials at Liverpool Cancer Therapy Centre', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 14, pp. 168 - 169, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449544200283&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Do V; Ng W; Jacob S; Delaney G; Barton M, 2018, 'An estimation of the population-based survival benefit of first-course chemotherapy for advanced incurable cancer', in Annals of oncology : official journal of the European Society for Medical Oncology, OXFORD UNIV PRESS, Singapore, SINGAPORE, Vol. 29, pp. ix111, presented at European-Society-for-Medical-Oncology Asia Congress, Singapore, SINGAPORE, 23 November 2018 - 25 November 2018, http://dx.doi.org/10.1093/annonc/mdy440.006

Brungs D; Healey E; Rose J; Tubaro T; Ng W; Chua W; Carolan M; de Souza P; Aghmesheh M; Ranson M, 2016, 'Adjuvant chemotherapy for stage III colorectal cancer in the elderly', in Annals of Oncology, OXFORD UNIV PRESS, Copenhagen, DENMARK, Vol. 27, pp. vi182, presented at 41st Annual Congress of the European-Society-for-Medical-Oncology (ESMO), Copenhagen, DENMARK, 07 October 2016 - 11 October 2016, http://dx.doi.org/10.1093/annonc/mdw370.101

Wilkinson KJ; Chua W; Descallar J; Ng W; Roohullah A, 2016, 'SURGICAL MANAGEMENT OF ASYMPTOMATIC PRIMARY TUMORS IN STAGE IV COLORECTAL CANCER: WHO REALLY BENEFITS?', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, Vol. 12, pp. 71 - 71, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000380005100076&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Revoltar M; Shin J-S; Lim S; Tut T-G; Dissanayake I; Descallar J; Ho V; Chua W; Ng W; Lee M; Henderson C; De Souza P; Morgan M; Lee CS, 2016, 'Early marker of DNA damage response, atm, as a predictor of clinical outcome following radiotherapy in rectal cancer patients.', in Pathology, England, Vol. 48 Suppl 1, pp. S153, England, http://dx.doi.org/10.1016/j.pathol.2015.12.417

Lim SH; Ng W; Chua W; Descallar J; Spring K; De Souza P, 2015, 'Psychological parameters and circulating tumor cells in locally advanced rectal cancer', in Asia-Pacific Journal of Clinical Oncology, WILEY-BLACKWELL, Vol. 11, pp. 57 - 57, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000357957300039&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lim S; Ng W; Chua W; Descallar J; Spring K; De Souza P, 2015, 'Quality of life and circulating tumour cells in patients treated with neoadjuvant chemoradiation for rectal cancer - is there a link?', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, Vienna, AUSTRIA, Vol. 51, pp. S224 - S224, presented at European Cancer Congress, Vienna, AUSTRIA, http://dx.doi.org/10.1016/S0959-8049(16)30648-7

Girgis A; Delaney G; Arnold A; Miller A; Carolan M; Della-Fiorentina S; Kaadan N; Avery S; van Domburg N; Ng W; Spring K; Van Kemenade C; Maher A, 2014, 'THE PROMPT-CARE PROJECT: EHEALTH SYSTEM UTILISING PATIENT REPORTED OUTCOMES TO INFORM PERSONALISED CANCER TREATMENT AND CARE', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, Vol. 10, pp. 21 - 21, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344745100047&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Girgis A; Delaney G; Arnold A; Miller A; Carolan M; Della-Fiorentina S; Kaadan N; Avery S; Domburg N; Ng W; Spring K; Jacobs J; Maher A, 2014, 'Translating Evidence into Practice Through the PROMPT-Care Project: Utilising Patient Reported Outcome Measures for Personalised Cancer Treatment and Care', in PSYCHO-ONCOLOGY, WILEY-BLACKWELL, Vol. 23, pp. 256 - 257, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344003700384&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Viet D; Weng N; Delaney GP; Barton MB, 2013, 'An estimation of the population survival benefit of first-line chemotherapy for upper gastrointestinal cancer', in Asia-Pacific Journal of Clinical Oncology, Wiley-Blackwell, Adelaide, Vol. 9, pp. 148, presented at COSA Annual Scientific Meeting, Adelaide, 12 November 2013 - 14 November 2013, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000325868800276&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1